Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alpharma To Market Institut Biochimique’s Flector NSAID Patch In U.S.

This article was originally published in The Pink Sheet Daily

Executive Summary

Alpharma plans to double its in-house sales force from 200 to 400 reps, plus add 200 contract sales reps to market Flector.

You may also be interested in...



Abraxis Buys Shimoda; Dyloject Stays With Javelin

Upfront cash seems “ridiculously low,” analyst tells “The Pink Sheet” DAILY.

Abraxis Buys Shimoda; Dyloject Stays With Javelin

Upfront cash seems “ridiculously low,” analyst tells “The Pink Sheet” DAILY.

Alpharma’s Flector NSAID Patch Off To A Strong Start, CEO Says

First topical NSAID patch garners 3,800 scripts in its first two weeks on the market.

Related Content

Topics

UsernamePublicRestriction

Register

PS066485

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel